Drugs / natural killer cell infusion
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01700946 Comparator | Apr 2013 → Jul 2021 | B-cell childhood acute lymphoblastic leukemia | St. Jude Children's Research Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | natural killer cell infusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01700946 ↗ |
| Modality | Cell therapy | “infusion of haploidentical natural killer (NK) cells” NCT01700946 ↗ |